Aspen Aerogels (NYSE:ASPN) Given New $22.00 Price Target at B. Riley

Aspen Aerogels (NYSE:ASPN) had its price target decreased by B. Riley from $35.00 to $22.00 in a report released on Wednesday morning,Benzinga reports. B. Riley currently has a buy rating on the construction company’s stock.

Other equities analysts also recently issued reports about the stock. Roth Mkm dropped their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 14th. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Wednesday. Seaport Res Ptn cut Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. Craig Hallum cut their price target on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Finally, Canaccord Genuity Group decreased their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.44.

Aspen Aerogels Stock Down 2.6 %

NYSE ASPN opened at $8.32 on Wednesday. The stock’s 50 day simple moving average is $11.85 and its 200 day simple moving average is $18.22. Aspen Aerogels has a one year low of $8.25 and a one year high of $33.15. The firm has a market cap of $682.38 million, a PE ratio of 51.98 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, sell-side analysts forecast that Aspen Aerogels will post 0.46 earnings per share for the current fiscal year.

Institutional Trading of Aspen Aerogels

A number of institutional investors and hedge funds have recently modified their holdings of ASPN. Lord Abbett & CO. LLC bought a new position in Aspen Aerogels during the 3rd quarter worth about $10,126,000. Oppenheimer & Co. Inc. raised its position in Aspen Aerogels by 167.2% during the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock worth $2,839,000 after acquiring an additional 64,154 shares in the last quarter. Sanders Morris Harris LLC lifted its stake in Aspen Aerogels by 337.5% in the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock valued at $436,000 after acquiring an additional 27,000 shares during the last quarter. Penserra Capital Management LLC bought a new position in shares of Aspen Aerogels in the 3rd quarter valued at about $1,342,000. Finally, Geode Capital Management LLC increased its stake in shares of Aspen Aerogels by 5.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after purchasing an additional 75,024 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.